Previous 10 | Next 10 |
home / stock / jnj / jnj articles
Shockwave Medical, Inc. (NASDAQ:SWAV) shares are trading higher Tuesday following a report suggesting Johnson & Johnson (NYSE:JNJ) is in talks ...
In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this ar...
Last week, Nvidia Corp (NASDAQ:NVDA) announced significant collaborations with Johnson & Johnson (NYSE:JNJ) and General Ele...
Thursday, Argenx SE (NASDAQ:ARGX) shares are trading higher in reaction to Chugai Pharmaceutical Co Ltd’s disappointing g...
Key Takeaways: GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary ...
CNBC host Jim Cramer has spotlighted several lesser-known partners of NVIDIA Corp (NASDAQ:NVDA) that could potentially benefit from the companyR...
Friday, the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted positively (8-3) favoring expanded use of Bristol Myers Squibb & C...
Amid the ongoing scrutiny from Congress, WuXi AppTec and its affiliates face another setback as the Biotechnology Innovation Organization...
Bayer AG (OTC:BAYRY) (OTC:BAYZF) is reportedly considering utilizing the Texas Two-Step bankruptcy approach to tackle the onslaught of lawsuit...
News, Short Squeeze, Breakout and More Instantly...
Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with treatment-resistant depression Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with tr...
2024-07-18 11:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 05:40:00 ET On July 17, Johnson & Johnson (NYSE: JNJ) announced second-quarter results that gave investors a lot to look forward to. Integration of newly acquired medical technology plus upcoming expansions of patent-protected medicines will help push the healthcare c...